Rockville, MD, Nov. 04, 2024 (GLOBE NEWSWIRE) -- The global post herpetic neuralgia treatment market is calculated to reach a size of US$ 822.4 million in 2024 and climb to US$ 1.38 billion by the end of 2034. The market is forecasted to expand at 5.3% …

Ottawa, Aug. 09, 2024 (GLOBE NEWSWIRE) -- The global spinal cord injury treatment market size is predicted to increase from USD 7.13 billion in 2023 to approximately USD 11 billion by 2032, according to a study published by Towards Healthcare a sister firm …

… healthcare access, shortages of skilled human resources, difficulty in manufacturing biologics, and … Pharmaceuticals AbbVie Inc. Polaryx Therapeutics Acorda Therapeutics Inc. Further, the report segments …

… , distribution, technical operations, program management, human resources, and information technology. Ms. Yi … number of biopharmaceutical organizations including Acorda Therapeutics, Achillion Pharmaceuticals, Valeant Pharmaceuticals, Breaburn …

… Operations, Business Development and Human Resources functions. Financial Expectations for … FAMPYRA® are registered trademarks of Acorda Therapeutics, Inc. 1AMPYRA® (dalfampridine) … under a licensing agreement with Acorda Therapeutics, as FAMPYRA® (prolonged- …

… PhD, Chief Technology Officer, Acorda Therapeutics Entrepreneurs: Sundeep Bhan, Co- … Vice President, Corporate Communications, Acorda Therapeutics Carly Kuper, VP, Public … , Senior Vice President of Human Resources, DWA Healthcare Communications Group …